Radiant Innovation

Radiant Innovation Capital Expenditures

The Capital Expenditures (CapEx) of Radiant Innovation (3373.TWO) as of Oct 23, 2026 is -8.04 M TWD. In the previous year, Capital Expenditures (CapEx) was -9.12 M TWD — a change of -11.91% (higher).

Capital Expenditures

-8.04 MTWD

YoY

-11.91%

Last updated:

Capital Expenditures (CapEx) of Radiant Innovation is 2025 -8.04 M TWD. Capital Expenditures (CapEx) of Radiant Innovation was 2024 -9.12 M TWD. It decreases by -11.91% higher compared to the previous year.

The Radiant Innovation Capital Expenditures history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Expenditures
Date
Capital Expenditures
Jan 1, 2018
-12.07 M TWD
Jan 1, 2019
-10.91 M TWD
Jan 1, 2020
-29.10 M TWD
Jan 1, 2021
-22.18 M TWD
Jan 1, 2022
-10.42 M TWD
Jan 1, 2023
-16.37 M TWD
Jan 1, 2024
-9.12 M TWD
Jan 1, 2025
-8.04 M TWD
The Radiant Innovation Capital Expenditures history
YEARCapital ExpendituresYoY
-8.04 MTWD-11.91%
-9.12 MTWD-44.28%
-16.37 MTWD+57.07%
-10.42 MTWD-53.02%
-22.18 MTWD-23.77%
-29.10 MTWD+166.78%
-10.91 MTWD-9.64%
-12.07 MTWD-9.04%
-13.27 MTWD+32.07%
-10.05 MTWD-92.63%
-136.32 MTWD+731.77%
-16.39 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Radiant Innovation Stock analysis

What does Radiant Innovation do? Radiant Innovation Inc. generates revenue through the design, manufacture, and sale of infrared technology products. The company's main products include infrared temperature measurement instruments, ear temperature guns, frontal temperature guns, and other body temperature measurement products, alongside carbon dioxide detectors, infrared thermal imagers, and blood glucose dedicated chipsets. These products are distributed domestically and internationally across Asia, the Americas, Europe, and other regions. The primary buyers are healthcare providers, medical facilities, and electronic component distributors who require precise measurement tools and specialized components for health monitoring and diagnostics. The firm's product portfolio targets healthcare and industrial segments, with infrared thermal imagers used in building inspections and carbon dioxide detectors deployed in environmental monitoring. Blood glucose dedicated chipsets are supplied to medical device manufacturers for integration into diagnostic equipment. International distribution channels focus on regions like Asia, the Americas, and Europe, where demand for health-related measurement devices remains strong. Revenue streams are driven by direct sales to medical institutions, electronic component distributors, and industrial clients. The company's product lines serve both consumer-facing health monitoring applications and specialized industrial uses, with a strong emphasis on accuracy and reliability in temperature and gas detection technologies. Radiant Innovation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Radiant Innovation stock

Capital Expenditures (CapEx) of Radiant Innovation is -8.04 M TWD in 2025.

Capital Expenditures (CapEx) of Radiant Innovation changed from -9.12 M TWD to -8.04 M TWD, representing a -11.91% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Capital Expenditures (CapEx) Radiant Innovation since 2006 – with annual values, charts, and detailed analysis.

Capital expenditures represent investments in long-term assets such as property, equipment, and technology. CapEx is essential for maintaining and growing the business.

Capital Expenditures (CapEx)'s TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Capital Expenditures (CapEx)'s Radiant Innovation historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Radiant Innovation

All Key Metrics — Radiant Innovation